Categories Earnings

Earnings Summary Of Glaxosmithkline Pharmaceuticals Limited For Q4 FY23

GlaxoSmithKline Pharmaceuticals Limited is a renowned Indian pharmaceutical company that operates in the research, development, manufacturing, and marketing of a wide range of prescription medicines, vaccines, and consumer healthcare products. As a subsidiary of the global healthcare giant Glaxosmithkline, the company carries forward its legacy of innovation, quality, and commitment to improving global health. The company operates through various business segments, including Pharmaceuticals and Consumer Healthcare. The Pharmaceuticals segment focuses on the development, manufacture, and marketing of prescription drugs across multiple therapeutic areas such as respiratory, dermatology, oncology, cardiovascular, and infectious diseases.

  • GlaxoSmithKline Pharmaceuticals Limited reported Total Income for Q4 FY23 of ₹815.11 Crore down from ₹828.39 Crore year on year, a decline of 1.6%.
  • Total Expenses for Q4 FY23 of ₹635.54 Crore down from ₹650.04 Crore year on year, a decline of 2.2%.
  • Consolidated Net Profit of ₹133.43 Crore, down 89% from ₹1219.05 Crore in the same quarter of the previous year.
  • The Earnings per Share is ₹7.88, from ₹71.96 in the same quarter of the previous year.

Most Popular

Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript

Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah

All you need to know about Antony Waste Handling Cell in one article

Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?

Demystifying the Leading Non-Ferrous Recycling Company of India

“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,

Top